Nonfamilial restrictive cardiomyopathy (Q42320): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (2 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: I30-I52 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 08:46, 13 August 2026
Nonfamilial restrictive cardiomyopathy is restrictive cardiomyopathy secondary to an acquired systemic disorder that is known to be associated with restrictive cardiomyopathy such as amyloidosis, scleroderma, sarcoidosis, or anthracycline therapy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | BC43.20 |
||
| English | Nonfamilial restrictive cardiomyopathy |
Nonfamilial restrictive cardiomyopathy is restrictive cardiomyopathy secondary to an acquired systemic disorder that is known to be associated with restrictive cardiomyopathy such as amyloidosis, scleroderma, sarcoidosis, or anthracycline therapy. |
Statements
CID11:BC43.20
0 references
dki-india-BC43.20
0 references
Concluído
0 references
13 August 2026
0 references
